Currently, there are 225.18M common shares owned by the public and among those 222.24M shares have been available to trade.
The company’s stock has a 5-day price change of 3.86% and -6.50% over the past three months. X shares are trading 15.50% year to date (YTD), with the 12-month market performance down to -15.31% lower. It has a 12-month low price of $26.92 and touched a high of $48.12 over the same period. X has an average intraday trading volume of 7.39 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 5.85%, 10.62%, and 5.40% respectively.
Institutional ownership of United States Steel Corp (NYSE: X) shares accounts for 86.63% of the company’s 225.18M shares outstanding.
It has a market capitalization of $8.84B and a beta (3y monthly) value of 1.88. The stock’s trailing 12-month PE ratio is 26.31, while the earnings-per-share (ttm) stands at $1.49. The company has a PEG of 1.82 and a Quick Ratio of 0.91 with the debt-to-equity ratio at 0.37. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.29% over the week and 4.06% over the month.
Analysts forecast that United States Steel Corp (X) will achieve an EPS of -0.3 for the current quarter, 0.43 for the next quarter and 3.41 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.41 while analysts give the company a high EPS estimate of -0.41. Comparatively, EPS for the current quarter was 0.82 a year ago. Earnings per share for the fiscal year are expected to decrease by -6.99%, and 70.59% over the next financial year.
Looking at the support for the X, a number of firms have released research notes about the stock. Morgan Stanley stated their Equal-Weight rating for the stock in a research note on February 03, 2025, with the firm’s price target at $39-$39. BofA Securities coverage for the United States Steel Corp (X) stock in a research note released on January 06, 2025 offered a Neutral rating with a price target of $35. JP Morgan was of a view on September 09, 2024 that the stock is Overweight, while Exane BNP Paribas gave the stock Outperform rating on September 06, 2024, issuing a price target of $40. BMO Capital Markets on their part issued Outperform rating on June 26, 2024.
